Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.
As opposition in Congress mounts to the White House’s decision to retain Ogilvy & Mather on its anti-drug media campaign, at least one of the losing contenders is considering filing a protest.
“We are trying to find out what is involved, what are the legalities and how to do this,” said one executive.
The protest will likely be filed after the White House Office of National Drug Control Policy debriefs the losing bidders this week about how the decision was reached, sources said.
Sources said Bates is considering filing a protest, but will not make a final decision until after the debriefing.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in